These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1453278)

  • 1. Microbiological validation of a new manufacturing complex for an injectable biological product.
    Carroll MC; Van Pala M; Vollherbst L
    J Parenter Sci Technol; 1992; 46(4):107-10. PubMed ID: 1453278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA perspective on specifications for biotechnology products--from IND to PLA.
    Murano G
    Dev Biol Stand; 1997; 91():3-13. PubMed ID: 9413677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of environmental monitoring methods and levels.
    Noble NH
    J Parenter Sci Technol; 1993; 47(1):26-8. PubMed ID: 8445496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal health pharmaceutical industry.
    Carnevale RA; Shryock TR
    Prev Vet Med; 2006 Feb; 73(2-3):217-20. PubMed ID: 16266763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design control and validation of a facility for sterile clinical trial preparations.
    Staines L
    J Parenter Sci Technol; 1984; 38(3):109-14. PubMed ID: 6747778
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of gene therapy products and the impact of manufacturing changes on product comparability.
    Simek SL
    Dev Biol (Basel); 2005; 122():139-44. PubMed ID: 16375258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of bioassays for the characterisation and control of biological therapeutic products produced by biotechnology.
    Thorpe R; Wadhwa M; Mire-Sluis A
    Dev Biol Stand; 1997; 91():79-88. PubMed ID: 9413686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and establishment of specifications for biopharmaceuticals.
    Davis GC; Riggin RM
    Dev Biol Stand; 1997; 91():49-54. PubMed ID: 9413683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and future issues in the manufacturing and development of monoclonal antibodies.
    Kozlowski S; Swann P
    Adv Drug Deliv Rev; 2006 Aug; 58(5-6):707-22. PubMed ID: 16828921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Microbiologic validation in the production of sterile pharmaceuticals].
    Pongiluppi S
    Boll Chim Farm; 1991 Jun; 130(6):203-12. PubMed ID: 1756004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine industry perspective of current issues of good manufacturing practices regarding product inspections and stability testing.
    Monahan TR
    Clin Infect Dis; 2001 Dec; 33 Suppl 4():S356-61. PubMed ID: 11709773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An animal origin perspective of common constituents of serum-free medium formulations.
    Jayme DW
    Dev Biol Stand; 1999; 99():181-7. PubMed ID: 10404889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Water treatment systems for pharmaceutical purposes.
    Pregnolato F
    Boll Chim Farm; 1990 Mar; 129(3):122-39. PubMed ID: 2245001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Validation of procedure for sterile manufacturing. Simulated distribution in containers, in a sterile area].
    Arecco D; Carazzone M; Fava M
    Boll Chim Farm; 1982 Oct; 121(10):493-502. PubMed ID: 7165749
    [No Abstract]   [Full Text] [Related]  

  • 15. Flexibility--the guiding principle for antibody manufacturing.
    Carson KL
    Nat Biotechnol; 2005 Sep; 23(9):1054-8. PubMed ID: 16151390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and regulation of monoclonal antibody products: challenges and opportunities.
    Weinberg WC; Frazier-Jessen MR; Wu WJ; Weir A; Hartsough M; Keegan P; Fuchs C
    Cancer Metastasis Rev; 2005 Dec; 24(4):569-84. PubMed ID: 16408162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boundary and airlock design issues in aseptic facilities.
    Lorenz MR; Robinson JE
    J Parenter Sci Technol; 1991; 45(6):279-85. PubMed ID: 1802984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products.
    Shankar G; Devanarayan V; Amaravadi L; Barrett YC; Bowsher R; Finco-Kent D; Fiscella M; Gorovits B; Kirschner S; Moxness M; Parish T; Quarmby V; Smith H; Smith W; Zuckerman LA; Koren E
    J Pharm Biomed Anal; 2008 Dec; 48(5):1267-81. PubMed ID: 18993008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specifications from a biotechnology industry perspective.
    Garnick RL
    Dev Biol Stand; 1997; 91():31-6. PubMed ID: 9413680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.